1. Health
You can opt-out at any time. Please refer to our privacy policy for contact information.

Discuss in my forum

Mary Shomon

Thyroid Awareness Month on the Web

By January 7, 2013

Follow me on:

January is Thyroid Awareness Month, and throughout the month, I'll be highlighting the various efforts, new content and information being disseminated as part of this international effort to raise thyroid awareness.

Here are a few things to get you started:

Thyroid Awareness Month Video

American Association of Clinical Endocrinologists / Thyroid Awareness Month Site

Pharmacists Support Thyroid Awareness Month

About Mary Shomon | Thyroid Forum | Twitter | Facebook

Image: Mary Shomon

January 8, 2013 at 2:36 pm
(1) Chris says:

today the preliminary results of the Company’s ASAP (Anatabloc Supplementation Autoimmune Prevention) Human Thyroid Study that analyzes the impact of anatabine dietary supplementation on thyroid health.

(Logo: http://photos.prnewswire.com/prnh/20120301/NE62741LOGO )

The study is a three-month, five-visit, double-blind, placebo-controlled study of the impact of anatabine dietary supplementation in humans with autoimmune disease of the thyroid. The study was conducted at nine sites and builds upon previous epidemiological and animal experimental studies. Initial results for all study subjects suggest that dietary supplementation with anatabine ameliorates the immune system’s targeting of the thyroid gland in autoimmune thyroiditis.

Subjects in the study were screened initially to establish the presence of active autoimmune thyroid inflammation. Baseline thyroid sonography, thyroid antibody levels, and cytokine levels were collected from the subjects who were determined to have active autoimmune thyroid inflammation. Thyroid function tests and routine safety monitoring were also done in these subjects. Eligible subjects were enrolled in the study and then received weight-appropriate doses of anatabine or placebo, ranging from nine to twenty-four mg of the anatabine supplement or placebo per day. Subjects received treatment for three months, returning at four-week intervals for repeat laboratory testing

Read more: http://www.benzinga.com/news/earnings/13/01/3221979/star-scientific-reports-positive-initial-results-of-asap-human-thyroid-h#ixzz2HPk9608d

Leave a Comment

Line and paragraph breaks are automatic. Some HTML allowed: <a href="" title="">, <b>, <i>, <strike>

©2014 About.com. All rights reserved.

We comply with the HONcode standard
for trustworthy health
information: verify here.